A case of Rothia dentocariosa bacteremia in a patient receiving infliximab for ulcerative colitis.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Darwin F
DF
Yeung
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Ashkan
A
Parsa
Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
John C
JC
Wong
Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Nazira
N
Chatur
Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Baljinder
B
Salh
D000192:Actinomycetales / Q000145:classification*; D000193:Actinomycetales Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D018570:Risk Assessment; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D000069285:Infliximab